AMERICA'S BIGGEST ACCESS, PRICING, AND REIMBURSEMENT EVENT.

 

 

 

 

 

  About Pharma Pricing & Market Access Congress

Discuss pricing, patient centricity and global market access all in one place. With collaboration high on the agenda, World Pharma Pricing and Market Access gives you excellent opportunities to hear from payers, pharma, patient led organisations and providers. Attend America's biggest event in access, pricing, and reimbursement.

PPMA USA is co-located with:

Evidence EU 2017
 

DOWNLOAD BROCHURE

85 CONFIRMED SPEAKERS AND COUNTING

  • Anna Bucsics at Pharma Pricing and Market Access USA 2017
    Anna Bucsics
    Project Advisor
    University of Vienna
    Keely Dahl at Pharma Pricing and Market Access USA 2017
    Keely Dahl
    Associate Medical Director Biologics
    Novo Nordisk
    David Davidovic at Pharma Pricing and Market Access USA 2017
    David Davidovic
    Founder, pathForward, Former VP and Global Head, Commercial Services
    Roche Genentech
  • Peter Dehnel at Pharma Pricing and Market Access USA 2017
    Peter Dehnel
    Medical Director
    Blue Cross and Blue Shield of Minnesota
    Tao Fan at Pharma Pricing and Market Access USA 2017
    Tao Fan
    Director of Evidence Based Medicine and Medical Affairs
    Sanofi Inc
    Sachin Kamal-Bahl at Pharma Pricing and Market Access USA 2017
    Sachin Kamal-Bahl
    Vice President & Head, Global Health & Value Innovation Center
    Pfizer
  • Olaf Koester at Pharma Pricing and Market Access USA 2017
    Olaf Koester
    Director
    Manitoba Health
    Christine Lu at Pharma Pricing and Market Access USA 2017
    Christine Lu
    Co-Director of the PRecisiOn Medicine Translational Research (PROMoTeR) Center
    Harvard Pilgrim Health Care
    Kevin Mayo at Pharma Pricing and Market Access USA 2017
    Kevin Mayo
    Ex Senior Director, Global Patient (Market) Access - Commerical Strategy and Consumer Operations
    Shire Pharmaceuticals
  • Jeff Myers at Pharma Pricing and Market Access USA 2017
    Jeff Myers
    CEO
    Medicaid Health Plans of America
    David Nash, MD MBA at Pharma Pricing and Market Access USA 2017
    David Nash, MD MBA
    Dean/Board of Directors
    Jefferson College of Population Health
    Edmund Pezalla at Pharma Pricing and Market Access USA 2017
    Edmund Pezalla
    Former VP Pharmaceutical Policy and Strategy
    Aetna
  • S D Ravetkar at Pharma Pricing and Market Access USA 2017
    S D Ravetkar
    Executive Director
    Serum Institute of India Ltd
    Michael Reilly at Pharma Pricing and Market Access USA 2017
    Michael Reilly
    Executive Director
    Alliance for Safe Biologic Medicines
    Jamie Skipper at Pharma Pricing and Market Access USA 2017
    Jamie Skipper
    Former, ONC - Patient Centered Outcomes Research/HIT Policy
    HSS
  • Lotte Steuten at Pharma Pricing and Market Access USA 2017
    Lotte Steuten
    Associate Faculty Member
    Fred Hutchinson Cancer Research Center
    Dr Boxiong Tang at Pharma Pricing and Market Access USA 2017
    Dr Boxiong Tang
    Senior Director
    Teva Pharmaceuticals United State of America
    Riad Dirani at Pharma Pricing and Market Access USA 2017
    Riad Dirani
    Riad Dirani, Vice President, Global Health Economics and Outcomes Research
    Teva Pharmaceuticals
  • Ashley John at Pharma Pricing and Market Access USA 2017
    Ashley John
    Senior Specialist, Advocacy and Policy
    American Academy of Dermatology
    Roberta Monteiro at Pharma Pricing and Market Access USA 2017
    Roberta Monteiro
    Market Access and Commercial Director Brazil
    Eisai
    Jason Simeone at Pharma Pricing and Market Access USA 2017
    Jason Simeone
    Research Scientist, Real-World Evidence
    Evidera
  • Rafael Alfonso at Pharma Pricing and Market Access USA 2017
    Rafael Alfonso
    Director, Analytics and Innovation, Value Evidence and Outcomes
    GSK
    Rachel Anhorn at Pharma Pricing and Market Access USA 2017
    Rachel Anhorn
    Director, Payer Policy and Health Outcomes
    Foundation Medicine Inc
    Bhakti Arondekar at Pharma Pricing and Market Access USA 2017
    Bhakti Arondekar
    Senior Director, Global & US Immuno/Oncology Team Leader, Outcomes & Evidence
    Pfizer
  • James Barbeau at Pharma Pricing and Market Access USA 2017
    James Barbeau
    Director of Clinical Pathology
    Lifespan/Brown University
    Lauren Bartolome at Pharma Pricing and Market Access USA 2017
    Lauren Bartolome
    HEOR Fellow
    Novartis
    Alberto Batista at Pharma Pricing and Market Access USA 2017
    Alberto Batista
    HEOR fellow
    Teva Pharmaceuticals
  • Elise Berliner, Ph.D. at Pharma Pricing and Market Access USA 2017
    Elise Berliner, Ph.D.
    Director, Technology Assessment Programme
    Agency for Healthcare Research and Quality - U.S. Department of Health and Human Services
    Jennifer Bragg at Pharma Pricing and Market Access USA 2017
    Jennifer Bragg
    Partner
    Skadden Arps Slate Meagher & Flom LLP
    Bruce Broad at Pharma Pricing and Market Access USA 2017
    Bruce Broad
    Clinical Professor of Dermatology at Perelman School of Medicine
    University of Pennsylvania
  • Catherine Brownstein at Pharma Pricing and Market Access USA 2017
    Catherine Brownstein
    Scientific Director
    Manton Center for Orphan Disease Research
    Steve Clark at Pharma Pricing and Market Access USA 2017
    Steve Clark
    Vice President of Business Development and Consulting
    Optum Life Sciences
    Mark Cziraky at Pharma Pricing and Market Access USA 2017
    Mark Cziraky
    Vice President of Researce Healthcore
    Anthem
  • Jill Davies at Pharma Pricing and Market Access USA 2017
    Jill Davies
    COO
    Gene Matters
    Julia Gaebler at Pharma Pricing and Market Access USA 2017
    Julia Gaebler
    Former Senior Director of Global Medical Outcomes Strategy
    Biogen Idec
    Bill Goodson at Pharma Pricing and Market Access USA 2017
    Bill Goodson
    Deputy Director of Pricing Reimbursement and Patient Assistance
    Eisai
  • Andy Gunn at Pharma Pricing and Market Access USA 2017
    Andy Gunn
    Global Head Evidence Generation
    UCB Pharma
    James Harnett at Pharma Pricing and Market Access USA 2017
    James Harnett
    Sr. Director, Analytical Sciences Lead, Real World Data and Analytics, Global Health and Value
    Pfizer
    Katherine Hempstead at Pharma Pricing and Market Access USA 2017
    Katherine Hempstead
    Senior Adviser to the Executive Vice President
    Robert Wood Johnson Foundation
  • Athula Herath at Pharma Pricing and Market Access USA 2017
    Athula Herath
    Global Head of Real world Evidence Disease Epidemiology
    Novartis
    Jonathan Jarrow at Pharma Pricing and Market Access USA 2017
    Jonathan Jarrow
    Senior Medical Advisor to the Center Director of CDER
    F.D.A
    Adam Kautzner at Pharma Pricing and Market Access USA 2017
    Adam Kautzner
    Vice President, Formulary & Drug Trends Solutions
    Express Scripts
  • Karen Keeley at Pharma Pricing and Market Access USA 2017
    Karen Keeley
    Consultant
    R.A.R.E. Science
    Dan Klein at Pharma Pricing and Market Access USA 2017
    Dan Klein
    President and Chief Executive Officer
    Patient Access Network Foundation
    Brett Kopelan at Pharma Pricing and Market Access USA 2017
    Brett Kopelan
    Executive Director
    DebRa of America
  • Shanthy Krishnaraja at Pharma Pricing and Market Access USA 2017
    Shanthy Krishnaraja
    Head of Global Health Economics and Reimbursement Strategy
    C.S.L. Behring
    Sonia Lee at Pharma Pricing and Market Access USA 2017
    Sonia Lee
    HEOR Fellow
    Ethicon Inc
    Julie Locklear at Pharma Pricing and Market Access USA 2017
    Julie Locklear
    Vice President and Head of Health Economics and Outcomes Research
    EMD Serono
  • Ben locwin at Pharma Pricing and Market Access USA 2017
    Ben locwin
    Ex-Executive Director Roche President, Healthcare Science Advisors
    Roche & Genentech
    Steinar Madsen at Pharma Pricing and Market Access USA 2017
    Steinar Madsen
    Medical Director
    Norwegian Medicines Agency, Norway
    Bill Martin at Pharma Pricing and Market Access USA 2017
    Bill Martin
    Vice President, Pharma Strategy and Account Management
    Express Scripts and Accredo
  • John Maslowski at Pharma Pricing and Market Access USA 2017
    John Maslowski
    CEO
    Fibrocell Science Inc
    Christina Matteucci at Pharma Pricing and Market Access USA 2017
    Christina Matteucci
    Market Access Head, Brazil
    Bristol Myers Squibb
    Michele McCourt at Pharma Pricing and Market Access USA 2017
    Michele McCourt
    Director
    Cancer Care Co-Payment Assistance Foundation
  • Sean McElligott at Pharma Pricing and Market Access USA 2017
    Sean McElligott
    Director, Market Access
    Janssen
    Jim McKay at Pharma Pricing and Market Access USA 2017
    Jim McKay
    Director, Clinical Development and Medical Affairs
    Sandoz
    Timothy Miller at Pharma Pricing and Market Access USA 2017
    Timothy Miller
    President, Chief Executive Officer and Director
    Abeona Therapeutics Inc.
  • Amy Niles at Pharma Pricing and Market Access USA 2017
    Amy Niles
    Vice President, External Affairs
    Patient Access Network Foundation P.A.N.
    Nneka Onwudiwe PharmD PhD MBA at Pharma Pricing and Market Access USA 2017
    Nneka Onwudiwe PharmD PhD MBA
    PRO/PE Regulatory Reviewer
    US Government
    Melissa Paige at Pharma Pricing and Market Access USA 2017
    Melissa Paige
    UVA Cancer Center, Oncology Patient Access Principal Coordinator, Patient Advocate
    U.V.A. Health System
  • Sachin Palod at Pharma Pricing and Market Access USA 2017
    Sachin Palod
    Vice President, Access & Value Solutions, Life Sciences
    Optum Life Sciences
    Leena Patel at Pharma Pricing and Market Access USA 2017
    Leena Patel
    President and CEO
    Patient Access Network Foundation
    Tanya Potashnik at Pharma Pricing and Market Access USA 2017
    Tanya Potashnik
    Director Policy & Economic Analysis, Patented Medicine Prices Review Board
    Goverment Of Canada
  • Tehseen Salimi at Pharma Pricing and Market Access USA 2017
    Tehseen Salimi
    Head of Medical Affairs-Primary Care and Women's Health
    Merck
    John Shea at Pharma Pricing and Market Access USA 2017
    John Shea
    Director Corporate Development
    Merck & Co Inc
    Vanja Sikirica at Pharma Pricing and Market Access USA 2017
    Vanja Sikirica
    Senior Director of Value Evidence and Outcomes
    GlaxoSmithKline
  • David Smith at Pharma Pricing and Market Access USA 2017
    David Smith
    Professor of Laboratory Medicine And Pathology
    Mayo Clinic
    Christine Verini at Pharma Pricing and Market Access USA 2017
    Christine Verini
    Chief Business Development Officer
    CancerCare
    Jennifer Voelker at Pharma Pricing and Market Access USA 2017
    Jennifer Voelker
    Post-doctoral HEOR fellow
    Jansen
  • Meredith Wadman at Pharma Pricing and Market Access USA 2017
    Meredith Wadman
    Policy Reporter, Science Magazine and author: The Vaccine Race: Science, Politics and the Human Costs of Defeating Disease.
    Viking
    Surrey Walton at Pharma Pricing and Market Access USA 2017
    Surrey Walton
    Associate Professor of Pharmacy Administration
    U.I.C.
    Christina Waters at Pharma Pricing and Market Access USA 2017
    Christina Waters
    President & Chief Executive Officer
    R.A.R.E. Science
  • James Wu at Pharma Pricing and Market Access USA 2017
    James Wu
    Senior Manager, Global Health Economics
    Amgen Inc
    Douglas Nanton at Pharma Pricing and Market Access USA 2017
    Douglas Nanton
    Market Access and Government Affairs - Western Canada and Ottawa
    Valeant Pharmaceuticals International
    Simon Lin at Pharma Pricing and Market Access USA 2017
    Simon Lin
    Chief Research Information Officer
    Nationwide Children's Hospital
  • John Stoeckle at Pharma Pricing and Market Access USA 2017
    John Stoeckle
    Physician
    Thomas Jefferson University Hospitals, Inc.
    Bert Vrijhoef at Pharma Pricing and Market Access USA 2017
    Bert Vrijhoef
    CIO & Senior Principal Investigator
    Panaxea & Maastricht Unniversity Medical Center

 

“Excellent presenters, their knowledge and enthusiasm meant attendees were well educated”

Senior Director, European Physician & Payer Forum

 

 

FIRST HEADS OF EVIDENCE CONFIRMED TO SPEAK: 
 

World Biosimilar Congress USA


Athula Herath, Global Head of Real World Evidence Disease Epidemiology

World Biosimilar Congress USA


James Harnett , Sr. Director, Analytical Sciences Lead, Real World Data and Analytics, Global Health and Value

World Biosimilar Congress USA

 
Shanthy Krishnaraja , Head of Global Economics and Reimbursement

REGISTER NOW

 

Pharma Pricing & Market Access 2017 brochure

Get more information

 

The prospectus for Pharma Pricing & Market Access Americas 2017 is now available to download.

See what makes the congress a must-attend event in access, pricing, and reimbursement.

 

DOWNLOAD PROSPECTUS

 

REGULATION REPRESENTATIVES CONFIRMED TO SPEAK: 
 

World Biosimilar Congress USA

 


Tanya Potashnik, Director Policy and Economic Analysis Branch, Patented Medicine Prices Review Board

World Biosimilar Congress USA

Steinar Madsen  , Medical Director, Norwegian Medicines Agency

World Biosimilar Congress USA


Jonathan Jarow , Senior Medical Advisor to the Center Director of CDER

REGISTER NOW

Sign up for email updates

SPONSORS & EXHIBITORS

  • Platinum Sponsor

    Optum at Pharma Pricing and Market Access USA 2017
  • Gold Sponsor

    INC Research/inVentiv Health at Pharma Pricing and Market Access USA 2017
  • Silver Sponsor

    Evidera at Pharma Pricing and Market Access USA 2017

MORE ABOUT THE SHOW

 

“Interesting speakers- useful updates on key topics, some thought provoking perspectives- Director, A Connect

 

 

Venue

Hilton Philadelphia City Avenue,
4200 City Avenue
Philadelphia, PA 


 

Conference times

October 10, 2017: 8:00am - 6:00pm
October 11, 2017: 8:00am - 4:00pm

 

Exhibition times

October 10, 2017: 8:00am - 6:00pm 
October 11, 2017: 8:00am - 4:00pm